Economic aspects of epilepsy and antiepileptic treatment: a review of the literature

References

• Adams RD, Victor M, Ropper AH. Principles of Neurology, Sixth Edition. Mc Graw-Hill, NY, USA, 313 (1997).
   Google Scholar
• Sander JW, Shorvon SD. Epidemiology of the epilepsies. J. Neurol. Neurosurg. Psychiatry 61, 433–443 (1996).
   PubMed Web of Science ®Google Scholar
• Sander JW. The epidemiology of epilepsy revisited. Curr. Opin. Neurol. 16, 165–170 (2003).
   PubMed Web of Science ®Google Scholar
• Heaney DC, Macdonald BK, Everitt A et al. Socioeconomic variation in incidence of epilepsy: prospective community based study in southeast England. Br. Med. J. 325, 1013–1016 (2002).
   PubMed Web of Science ®Google Scholar
• Leary LD, Morrell MJ. Update on new antiepileptic drugs in children. Primary Psychiatry 11(4), 40–45 (2004).
   Google Scholar
• Spencer S. Long-term outcome after epilepsy surgery. Epilepsia 37, 807–813 (1996).
   PubMed Web of Science ®Google Scholar
• Schachter SC, Wheless JW. Vagus nerve stimulation 5 years after approval: a comprehensive update. Neurology 59(4), S15–S20 (2002).
   PubMed Web of Science ®Google Scholar
• Beran RG. Economic analysis of epilepsy care. Epilepsia 40(8), 19–24 (1999).
   PubMedGoogle Scholar
• Al-Zakwani I, Hanssens Y, Deleu D et al. Annual direct medical cost and contributing factors to total cost of epilepsy in Oman. Seizure 12, 555–560 (2003).
   PubMed Web of Science ®Google Scholar
• Beghi E, Garattini L, Ricci E, Cornago D, Parazzini F. Direct cost of medical management of epilepsy among adults in Italy: a prospective cost-of-illness study (EPICOS). Epilepsia 45, 171–178 (2004).
   PubMedGoogle Scholar
• Begley CE, Famulari M, Annegers JF et al. The cost of epilepsy in the United Sates: an estimate from population-based clinical and survey data. Epilepsia 41, 342–351 (2000).
   PubMed Web of Science ®Google Scholar
• Begley CE, Lairson DR, Reynolds TF, Coan S. Early treatment cost in epilepsy and how it varies with seizure type and frequency. Epilepsy Res. 41, 205–215 (2001).
   Web of Science ®Google Scholar
• Berto P, Tinuper P, Viaggi S et al. Cost-of-illness of epilepsy in Italy. Data from a multicentre observational study (Episcreen). Pharmacoeconomics 17, 197–208 (2000).
   PubMed Web of Science ®Google Scholar
• de Zélicourt M, Buteau L, Fagnani F, Jallon P. The contributing factors to medical cost of epilepsy: an estimation based on a French prospective cohort study of patients with newly diagnosed epileptic Seizures (the CAROLE study). Seizure 9, 88–95 (2000).
   PubMed Web of Science ®Google Scholar
• Frost FJ, Hurley JS, Petersen HV, Gunter MJ, Gause D. A comparison of two methods for estimating the healthcare costs of epilepsy. Epilepsia 41, 1020–1026 (2000).
   PubMed Web of Science ®Google Scholar
• Garattini L, Ricci E, Roggeri D, Tediosi F, Beghi E, Parazzini F. Costs of epilepsy care in referral centers in Italy. Eur. J. Health Econ. 19, 87–99 (2000).
   Google Scholar
• Guerrini R, Battini R, Ferrari AR et al. The costs of childhood epilepsy in Italy: comparative findings from three healthcare settings. Epilepsia 42, 641–646 (2001).
   PubMed Web of Science ®Google Scholar
• Halpern M, Rentz A, Murray M. Cost of illness of epilepsy in the US: comparison of patient-based and population-based estimates. Neuroepidemiology 19, 87–99 (2000).
   PubMed Web of Science ®Google Scholar
• Jacoby A, Buck D, Baker G, McNamee P, Graham-Jones S, Chadwick D. Uptake and costs of care for epilepsy: findings from a UK regional study. Epilepsia 39, 776–786 (1998).
   PubMed Web of Science ®Google Scholar
• Kotsopoulos IA, Evers SM, Ament AJ et al. The costs of epilepsy in three different populations of patients with epilepsy. Epilepsy Res. 54, 131–140 (2003).
   PubMed Web of Science ®Google Scholar
• Krishnan A, Sahariah SA, Kapoor SK. Cost of epilepsy in patients attending a secondary-level hospital in India. Epilepsia 45, 289–291 (2004).
   PubMed Web of Science ®Google Scholar
• Mak W, Fong JK, Cheung RT, Ho ST. Cost of epilepsy in Hong Kong: experience from a regional hospital. Seizure 8, 456–464 (1999).
   PubMed Web of Science ®Google Scholar
• Nsengiyumva G, Druet-Cabanac M, Nzisabira L, Preux P, Vergnenegre A. Economic evaluation of epilepsy in Kiremba (Burundi): a case-control study. Epilepsia 45, 673–677 (2004).
   PubMed Web of Science ®Google Scholar
• Tetto A, Manzoni P, Millul A et al. The costs of epilepsy in Italy. A prospective cost-of-illness study in referral patients with disease of different severity. Epilepsy Res. 48, 207–216 (2002).
   PubMed Web of Science ®Google Scholar
• Thomas SV, Sarma PS, Alexander M et al. Economic burden of epilepsy in India. Epilepsia 42, 1052–1060 (2001).
   PubMed Web of Science ®Google Scholar
• Heaney DC, Shorvon SD, Sander JW. An economic appraisal of carbamazepine, lamotrigine, phenytoin and valproate as initial treatment in adults with newly diagnosed epilepsy. Epilepsia 39(3), S19–S25 (1998).
   PubMed Web of Science ®Google Scholar
• Heaney DC, Shorvon SD, Sander JW et al. Cost minimization analysis of anti-epileptic drugs in newly diagnosed epilepsy in 12 European countries. Epilepsia 41(5), S37–S44 (2000).
   PubMedGoogle Scholar
• Radhakrishnan K, Nayak S, Kumar S, Sarma P. Profile of anti-epileptic pharmacotherapy in a tertiary referral center in South India: a pharmacoepidemiological and pharmacoeconomic study. Epilepsia 40, 179–185 (1999).
   PubMed Web of Science ®Google Scholar
• Shakespeare A, Simeon G. Economic analysis of epilepsy treatment: a cost-minimization analysis comparing carbamazepine and lamotrigine in the UK. Seizure 7, 119–125 (1998).
   PubMed Web of Science ®Google Scholar
• Markowitz MA, Mauskopf JA, Halpern MT. Cost–effectiveness model of adjunctive lamotrigine for the treatment of epilepsy. Neurology 51, 1026–1033 (1998).
   PubMed Web of Science ®Google Scholar
• Platt M, Sperling M. A comparison of surgical and medical costs for refractory epilepsy. Epilepsia 43(4), S25–S31 (2002).
   PubMed Web of Science ®Google Scholar
• Rao MB, Radhakrishnan K. Is epilepsy surgery possible in countries with limited resources? Epilepsia 41(4), S31–S34 (2000).
   PubMed Web of Science ®Google Scholar
• Selai CE, Smith K, Trimble MR. Adjunctive therapy in epilepsy: a cost–effectiveness comparison of two AEDs. Seizure 8, 8–13 (1999).
   PubMed Web of Science ®Google Scholar
• Selai CE, Trimble MR, Lavett J. Pharmacoeconomics: a cost–effectiveness study of four anti-epileptic drugs. In: Benzodiazepines. Trimble MR, Hindmarch I (Eds), Wrightson Biomedical Publishing, Petersfield, UK, 131–146 (2000).
   Google Scholar
• van Hout BA, Gagnon DD, McNulty P, O’Hagan A. The cost–effectiveness of two new anti-epileptic therapies in the absence of direct comparative data. Pharmacoeconomics 21, 315–326 (2003).
   PubMed Web of Science ®Google Scholar
• Boon P, Vonck K, Vandekerckhove T et al. Vagus nerve stimulation for refractory epilepsy; efficacy and cost–benefit analysis. Acta Neurochir. 141, 447–453 (1999).
   PubMed Web of Science ®Google Scholar
• Boon P, D’Have M, Van Walleghem P et al. Direct costs of refractory epilepsy incurred by three different treatment modalities: a prospective assessment. Epilepsia 43, 96–102 (2002).
   PubMed Web of Science ®Google Scholar
• Forbes RB, Macdonald S, Eljamel S, Roberts RC. Cost–utility analysis of vagus nerve stimulators for adults with medically refractory epilepsy. Seizure 12, 249–256 (2003).
   PubMed Web of Science ®Google Scholar
• Messori A, Trippoli S, Becagli P et al. Adjunctive lamotrigine therapy in patients with refractory seizures: a lifetime cost–utility analysis. Eur. J. Clin. Pharmacol. 53, 421–427 (1998).
   PubMed Web of Science ®Google Scholar
• Annegers JF, Beghi E, Begley CE. Cost of epilepsy: contrast of methodologies in United States and European studies. Epilepsia 40(8), S14–S18 (1999).
   PubMed Web of Science ®Google Scholar
• Begley CE, Annegers JF, Lairson DR, Reynolds TF. Estimating the cost of epilepsy. Epilepsia 40(8), S8–S13 (1999).
   PubMedGoogle Scholar
• Begley CE, Beghi E. The economic cost of epilepsy: a review of the literature. Epilepsia 43(4), S3–S9 (2002).
   PubMedGoogle Scholar
• Brunetti M, Pagano E, Garattini L. The economic cost of epilepsy: a review. Ital. J. Neurol. Sci. 19, 116–119 (1998).
   PubMedGoogle Scholar
• Heaney DC, Sander JW. Ensuring appropriate care in epilepsy: an overview of epidemiological and cost of illness considerations. Dis. Manage Health Outcomes 4, 303–313 (1998).
   Google Scholar
• Kotsopoulos IA, Evers SM, Ament AJ, de Krom MC. Estimating the costs of epilepsy: an international comparison of epilepsy cost studies. Epilepsia 42, 634–640 (2001).
   PubMed Web of Science ®Google Scholar
• Langfitt JT. Cost evaluations in epilepsy: an update. Epilepsia 41(2), S62–S68 (2000).
   PubMed Web of Science ®Google Scholar
• Levy P. Economic evaluation of anti-epileptic drug therapy: a methodologic review. Epilepsia 43, 550–558 (2002).
   PubMed Web of Science ®Google Scholar
• Heaney D. The pharmacoeconomics of the new anti-epileptic drugs. Epilepsia 40(8), S25–S31 (1999).
   PubMedGoogle Scholar
• Levy P. Pharmacoeconomic evaluation of medical treatment of epilepsy: where do we stand? Acta Neurol. Belg. 99, 239–246 (1999).
   PubMed Web of Science ®Google Scholar
• Heaney DC, Sander JA, Shorvon SD. Comparing the cost of epilepsy across eight European countries. Epilepsy Res. 43, 89–95 (2001).
   PubMed Web of Science ®Google Scholar
• Schlienger RG, Oh PI, Knowles SR, Shear NH. Quantifying the costs of serious adverse drug reactions to anti-epileptic drugs. Epilepsia 39(7), S27–S32 (1998).
   PubMed Web of Science ®Google Scholar
• Shorvon SD. Safety of topiramate: adverse events and relationships to dosing. Epilepsia 37(2), S18–S22 (1996).
   PubMed Web of Science ®Google Scholar
• Matsuo F, Bergen D, Faught E et al. Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. Neurology 43, 2284–2291 (1993).
   PubMed Web of Science ®Google Scholar
• Begley CE, Annegers JF, Lairson DR, Reynolds TF, Hauser WA. Cost of epilepsy in the United States: a model based on incidence and prognosis. Epilepsia 35, 1230–1243 (1994).
   PubMed Web of Science ®Google Scholar
• Stavem K. Quality of life in epilepsy: comparison of four preference measures. Epilepsy Res. 29, 201–209 (1998).
   PubMed Web of Science ®Google Scholar
• Remak E, Hutton J, Selai CE, Trimble MR, Price MJ. A cost–utility analysis of adjunctive treatment with newer anti-epileptic drugs in the UK. J. Med. Econ. 7, 29–40 (2004).
   Google Scholar
• Begley CE, Beghi E, Beran R et al. ILAE Commission on the burden of epilepsy, Subcommission on the economic burden of epilepsy: final report 1998–2001. Epilepsia 43, 668–673 (2002).
   PubMed Web of Science ®Google Scholar